Cell Cycle Control of T Cell Apoptosis Induced by Activation Through the T Cell Antigen Receptor

  • N. Jan Chalupny
  • Liqing Zhu
  • Xue-zhong Yu
  • Claudio Anasetti
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 406)

Abstract

The term apoptosis refers to the morphological process of programmed cell death, a physiological event that occurs at specific stages of normal embryonic development as well as in adult life.1 During programmed cell death, cells undergo profound structural changes. The plasma membrane becomes ruffled or ‘blebbed’. The nucleus shrinks, but the morphology of other cytoplasmic organelles remains relatively unchanged. Within the nucleus, the chromatin condenses, and tends to collapse into patches around the nuclear envelope. Condensation of the chromatin is often accompanied by fragmentation of the DNA, caused by internucleosomal cleavage, resulting in the characteristic ‘ladder’ pattern of bands seen upon electrophoretic separation. The cell may finally break up into apoptotic bodies, which are rapidly phagocytosed.2–4

Keywords

Programme Cell Death Induce Cell Death Jurkat Cell Thymidine Uptake Mutant Cell Line 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    L. Sachs, and J. Lotem, Control of programmed cell death in normal and leukemic cells: new implications for therapy, Blood. 82: 15 (1993).PubMedGoogle Scholar
  2. 2.
    J.F.R. Kerr, A.H. Wyllie, and A.R. Currie, Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics, Br. J. Cancer. 26: 239 (1972).PubMedCrossRefGoogle Scholar
  3. 3.
    J.J. Cohen, R.C. Duke, V.A. Fadok, and K.S. Sellins, Apoptosis and programmed cell death in immunity, Annu. Rev. Immunol. 10: 267 (1992).PubMedCrossRefGoogle Scholar
  4. 4.
    A.H. Wyllie, J.F.R. Kerr, and A.R. Currie, Cell death: the significance of apoptosis, Int. Rev. Cytol. 68: 251 (1980).PubMedCrossRefGoogle Scholar
  5. 5.
    J.J. Cohen, Programmed cell death in the immune system, Adv. Immunol. 50: 55 (1991).PubMedCrossRefGoogle Scholar
  6. 6.
    C.A. Smith, G.T. Williams, R. Kingston, E.J. Jenkins, and J.J.T. Owen, Antibodies to CD3/T-cell receptor complex induce death by apoptosis in immature T cells in thymic cultures, Nature 337: 181 (1989).PubMedCrossRefGoogle Scholar
  7. 7.
    Y.F. Shi, R.P. Bissonnette, N. Parfray, M. Szalay, R.T. Kuboto, and D.R. Green, In vivo administration of monoclonal antibodies to the CD3 T cell receptor complex induces cell death (apoptosis) in immature thymocytes, J. Immunol. 146: 3340 (1991).Google Scholar
  8. 8.
    B. Wang, C. Biron, J. She, K. Higgins, M.J. Sunshine, E. Lacy, N. Lonberg, and C. Terhorst, A block in both early T lymphocyte and natural killer cell development in transgenic mice with high copy numbers of the human CD3E gene, Proc. Natl. Acad. Sci. USA 91: 9402 (1994).PubMedCrossRefGoogle Scholar
  9. 9.
    J.D. Ashwell, R.E. Cunningham, P.D. Noguchi, and D. Hernandez, Cell growth cycle block of T cell hybridomas upon activation with antigen, J. Exp. Med. 165: 173 (1987).PubMedCrossRefGoogle Scholar
  10. 10.
    S. Takahashi, H.T. Maecker, and R. Levy, DNA fragmentation and cell death mediated by T cell antigen receptor/CD3 complex on a leukemia T cell line, Eur. J. Immunol. 19: 1911 (1989).PubMedCrossRefGoogle Scholar
  11. 11.
    L. Zhu, and C. Anasetti, Cell cycle control of apoptosis in human leukemic T cells, J. Immunol. 154:192 (1995).Google Scholar
  12. 12.
    D. Kaebelitz, T. Pohl, and K. Pechhold, Activation-induced cell death (apoptosis) of mature peripheral T lymphocytes, Immunol. Today 147: 338 (1993).CrossRefGoogle Scholar
  13. 13.
    J.H. Russell, B. Rush, C. Weaver, and R. Wang, Mature T cells of autoimmune 1pr/lpr mice have a defect in antigen-stimulated suicide, Proc. Natl. Acad. Sci. USA 90: 4409 (1993).PubMedCrossRefGoogle Scholar
  14. 14.
    J. Dhein, H. Waciczak, C. Baumier, K-M. Debatin, and P.H. ‘Crammer, Autocrine T-cell suicide mediated by APO-1/(Fas/CD95), Nature 373: 438 (1995).PubMedCrossRefGoogle Scholar
  15. 15.
    T. Brunner, R.J. Mogil, D. LaFace, N.J. Yoo, A. Mahboubl, F. Echeverri, S.J. Martin W.R. Force, D.H. Lynch, C.F. Ware, and D.R. Green, Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas, Nature 373: 441 (1995).PubMedCrossRefGoogle Scholar
  16. 16.
    S-T. Ju, D.J. Panka, H. Cui, R. Ettinger, M. El-Khatib, D.H. Sherr, B.Z. Stanger, and A. Marshak-Rothstein, Fas (CD95)/Fas L interactions required for programmed cell death after T-cell activation, Nature 373: 444 (1995).PubMedCrossRefGoogle Scholar
  17. 17.
    Y.L. Yang, M. Mercep, C.F. Ware, and J.D. Ashwell, Fas and activation-induced Fas ligand mediate apoptosis of T cell hybridomas-inhibition of Fas ligand expression by retinoic acid and glucocorticoids, J. Exp. Med. 181: 1673 (1995).PubMedCrossRefGoogle Scholar
  18. 18.
    F. Vignaux, E. Vivier, B. Malissen, V. Depraetere, S. Nagata, and P. Golstein, TCR/CD3 coupling to Fas-based cytotoxicity, J. Exp. Med. 181: 781 (1995).PubMedCrossRefGoogle Scholar
  19. 19.
    M. Mercep, J.A. Bluestone, P.D. Noguchi, and J.D. Ashwell, Inhibition of transformed T cell growth in vitro by monoclonal antibodies directed against distinct activating molecules, J. Immunol. 140: 324 (1987).Google Scholar
  20. 20.
    M.J. Lenardo, Interleukin-2 programs mouse aß T lymphocytes for apoptosis, Nature 353: 858 (1991).PubMedCrossRefGoogle Scholar
  21. 21.
    S.A. Boehme, and M.J. Lenardo, Propriocidal apoptosis of mature T lymphocytes occurs at S phase of the cell cycle, Eur. J. Immunol. 23: 1552 (1993).PubMedCrossRefGoogle Scholar
  22. 22.
    C. Anasetti, P. Tan, J.A. Hansen, and P.J. Martin, Induction of specific nonresponsiveness in unprimed human T cells by anti-CD3 antibody and alloantigen, J. Exp. Med. 172: 1691 (1990).PubMedCrossRefGoogle Scholar
  23. 23.
    D.B. Straus, and A. Weiss, Genetic evidence for the involvement of the Ick tyrosine kinase in signal transduction through the T cell antigen receptor, Cell 70: 585 (1992).PubMedCrossRefGoogle Scholar
  24. 24.
    N. Oyaizu, S. Than, T.W. McCloskey, and S. Pahwa, Requirement of p561ck in T-cell receptor/CD3-mediated apoptosis and Fas-ligand induction in Jurkat cells, Biochem. Biophys. Res. Commun. 213: 994 (1995).PubMedCrossRefGoogle Scholar
  25. 25.
    K.M. Murphy, A.B. Heimberger, and D.Y. Loh, Induction by antigen of intrathymic apoptosis of CD4+CD8+TCR10 thymocytes in vivo, Science 250: 1720 (1990).PubMedCrossRefGoogle Scholar
  26. 26.
    S.A. Kostelny, M.S. Cole, and J.Y. Tso, Formation of a bispecific mAb by the use of leucine zippers, J. Immunol. 148: 1547 (1992).PubMedGoogle Scholar
  27. 27.
    A.K. Abbas, A.H. Lichtman, and J.S. Pober, Molecular basis of T cell antigen recognition and activation, in: “Cellular and Molecular Immunology,” W.B. Saunders Co., Philadelphia (1991).Google Scholar
  28. 28.
    R. Fotedar, J. Flatt, S. Gupta, R.L. Margolis, P. Fitzgerald, H. Messier, and A. Fotedar, Activation-induced T-cell death is cell cycle dependent and regulated by cyclin B, Mol. Cell. Biol. 15: 932 (1995).PubMedGoogle Scholar
  29. 29.
    A.T. Hoang, K.J. Cohen, J.F. Barrett, D.A. Bergstrom, and C.V. Dang, Participation of cyclin A in myc-induced apoptosis, Proc. Natl. Acad. Sci. USA 91: 6875 (1994).PubMedCrossRefGoogle Scholar
  30. 30.
    W. Meikrantz, S. Gisselbrecht, S.W. Tam, and R. Schlegel, Activation of cyclin A- dependent protein kinases during apoptosis, Proc. Natl. Acad. Sci. USA 91: 3754 (1994).PubMedCrossRefGoogle Scholar
  31. 31.
    S. Miyatake, H. Nakano, S.Y. Pak, T. Yamazaki, K. Takase, H. Matsushime, A. Kato, and T. Saito, Induction of G1 arrest by down-regulation of cyclin D3 in T cell hybridomas, J. Exp. Med. 182: 401 (1995).PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1996

Authors and Affiliations

  • N. Jan Chalupny
    • 1
  • Liqing Zhu
    • 1
  • Xue-zhong Yu
    • 1
  • Claudio Anasetti
    • 1
  1. 1.Human Immunogenetics Program Division of Clinical ResearchFred Hutchinson Cancer Research CenterSeattleUSA

Personalised recommendations